Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 105899
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.105899
Table 2 Comparison of treatment characteristics of women and men depending on age, n (%)
Parameter
Women 15-44 years, n = 3118
Men 15-44 years, n = 4163
P value
Women 45-55 years, n = 1689
Men 45-55 years, n = 2185
P value
Women > 55 years, n = 4650
Men > 55 years, n = 3181
P value
History of previous therapy0.0010.00060.06
Treatment-naïve2748 (88.13)3550 (85.28)1399 (82.83)1704 (77.99)3572 (76.86)2369 (74.5)
Treatment-experienced370 (11.87)613 (14.72)290 (17.17)481 (22.01)1076 (23.14)811 (25.5)
Current regimen< 0.0010.00040.02
Genotype-specific1573 (50.45)1817 (43.65)823 (48.73)930 (42.56)2872 (61.76)1869 (58.76)
Pangenotypic1545 (49.55)2346 (56.35)866 (51.27)1255 (57.44)1778 (38.24)1312 (41.24)

  • Citation: Dobrowolska K, Zarębska-Michaluk D, Pawłowska M, Tudrujek-Zdunek M, Lorenc B, Berak H, Janczewska E, Mazur W, Janocha-Litwin J, Klapaczyński J, Sitko M, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs. World J Hepatol 2025; 17(6): 105899
  • URL: https://www.wjgnet.com/1948-5182/full/v17/i6/105899.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v17.i6.105899